BX Swiss TOP 30 CHF
1.363,98
PKT
-8,37
PKT
-0,61
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 29.01.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 29.01.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 29.01.25 | Swiss Re Buy | UBS AG | |
| 28.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 28.01.25 | Givaudan Neutral | UBS AG | |
| 28.01.25 | Swiss Re Equal Weight | Barclays Capital | |
| 28.01.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 28.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Roche Neutral | UBS AG | |
| 27.01.25 | Novartis Buy | UBS AG | |
| 27.01.25 | Givaudan Add | Baader Bank | |
| 27.01.25 | Givaudan Add | Baader Bank | |
| 27.01.25 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Givaudan Underweight | Barclays Capital | |
| 24.01.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.01.25 | Givaudan Add | Baader Bank | |
| 24.01.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 24.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 22.01.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 21.01.25 | Richemont Outperform | Bernstein Research | |
| 21.01.25 | Richemont Sector Perform | RBC Capital Markets | |
| 20.01.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 20.01.25 | Richemont Overweight | Barclays Capital | |
| 20.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 20.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 20.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 17.01.25 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 17.01.25 | Richemont Buy | UBS AG |